Sunshine Biopharma Inc. Acquires Nora Pharma Inc.
October 20, 2022
Sunshine Biopharma Inc. has completed the acquisition of all outstanding shares of Nora Pharma Inc., making Nora Pharma a wholly owned subsidiary. The deal (C$30.0 million) expands Sunshine’s business into generic prescription drugs, over‑the‑counter products and biosimilars and adds approximately $10.7 million in revenue and 36 employees based in the Greater Montreal area.
- Buyers
- Sunshine Biopharma Inc.
- Targets
- Nora Pharma Inc.
- Industry
- Pharmaceuticals
- Location
- Quebec, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Sun Pharma to Acquire Organon in $11.75 Billion All-Cash Deal
April 26, 2026
Healthcare Services
Sun Pharmaceutical Industries (Sun Pharma) entered into a definitive agreement to acquire all outstanding shares of Organon for $14.00 per share in an all-cash transaction valuing Organon at an enterprise value of $11.75 billion. The deal is expected to close in early 2027, subject to customary regulatory approvals and Organon stockholder approval.
-
Pharmaron Acquires 82.54% of Biortus Biosciences
October 28, 2025
Healthcare Services
Pharmaron Beijing Co., Limited has entered into a definitive Share Purchase Agreement to acquire 82.54% of Biortus Biosciences Co., Ltd. and its affiliates. The transaction is expected to close after satisfaction of customary closing conditions and is intended to strengthen Pharmaron’s structure-based drug discovery and protein science capabilities.
-
Bora Pharmaceuticals Acquires Upsher-Smith Laboratories
August 5, 2025
Pharmaceuticals
Bora Pharmaceuticals completed a 2024 acquisition of Upsher-Smith Laboratories for $210 million and is expanding the Maple Grove, Minnesota manufacturing site with a multi-year buildout. The investment includes installation of a Gerteis Macro-Pactor (operational Q3 2025) and development of 100,000 square feet of shell space to boost oral solid dose (OSD) contract development and manufacturing capabilities.
-
Apotex Acquires Searchlight Pharma
April 2, 2024
Pharmaceuticals
Apotex Inc. has completed the acquisition of Montreal-based Searchlight Pharma Inc., integrating Searchlight as Apotex's Specialty Pharma Division to expand its branded and specialty pharmaceutical capabilities. The deal adds Searchlight's portfolio of more than 60 products across women's health, dermatology, allergy, pain management and hospital specialty markets, and strengthens Apotex's commercial footprint in Quebec and across the Americas.
-
SUNRx Acquires AuthorityRx
September 21, 2023
Healthcare Services
SUNRx, a San Diego-based healthcare technology company and 340B administrator, has acquired AuthorityRx, a Kansas City–area technology and pharmacy consulting firm. The deal adds AuthorityRx's auditing and compliance services plus two cloud-based applications (including the Advanced Claims Capture product) to SUNRx's 340B offerings to improve referral claims capture and increase savings for covered entities.
-
Searchlight Pharma Inc. to Acquire Miravo Healthcare (Nuvo Pharmaceuticals d/b/a Miravo Healthcare)
February 7, 2023
Healthcare Services
Miravo Healthcare (Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare) announced it has filed and is mailing special meeting materials for a shareholder vote on a proposed plan of arrangement with Searchlight Pharma Inc. Under the arrangement, Searchlight Pharma will acquire all issued and outstanding common shares of Miravo for cash consideration of $1.35 per share.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.